Cicek, Ayla Uzun2024-10-262024-10-2620201018-86811309-5749https://doi.org/10.14744/DAJPNS.2020.00081https://search.trdizin.gov.tr/tr/yayin/detay/360812https://hdl.handle.net/20.500.12418/27532Stuttering is a communication disorder characterized by a disruption in normal fluency and time patterning of speech. None of the pharmacological agents for stuttering could be recommended for general use; specific drug treatment that is simultaneously effective for both stuttering and attention deficit hyperactivity disorder (ADHD) is currently unknown. In this article, we present a case affected by severe developmental stuttering and ADHD that was exacerbated by atomoxetine but favorably responded to treatment with methylphenidate.en10.14744/DAJPNS.2020.00081info:eu-repo/semantics/openAccessAtomoxetineattention deficit hyperactivity disorderchild/adolescentmethylphenidatestutteringArticle3322132102-s2.0-85091154064Q3360812WOS:000575007800013N/A